07:57 GMT27 January 2021
Listen Live
    Latin America
    Get short URL

    MEXICO CITY (Sputnik) - The Mexican government, following a visit to Argentina, where the production of the Russian Sputnik V coronavirus vaccine will be organized, said it had reached preliminary agreements on the purchase of up to 24 million doses of the drug, Deputy Health Secretary Hugo Lopez-Gatell told reporters.

    According to him, meetings with Russian officials, both scientists and the side that controls access to this vaccine have been held and the preliminary agreements would potentially give the Mexican government the opportunity to receive vaccines produced under a patent from the Russian Gamaleya Institute.

    "We think we could use up to 24 million doses of this vaccine for 12 million people, since the Sputnik V vaccination scheme envisions the use of two doses of this biological product," the deputy secretary said.

    According to the official, during the visit to Argentina, the Mexican side was able to learn the missing information on the safety and effectiveness of the vaccine, and the concerns from a number of medical communities caused by a lack of information coming from direct official contacts were preliminarily resolved.

    Production of the Russian Sputnik V coronavirus vaccine is slated to be launched in Argentina in the second quarter of 2021. Kirill Dmitriev, head of the Russian Direct Investment Fund (RDIF), making the statement, said Argentina had a number of "very powerful pharmaceutical companies" that could produce the vaccine.


    Russian Vaccine Sputnik V to Start Phase 3 Trials in Mexico Once Registered, Ambassador Says
    Live Updates: Mexico's COVID-19 Death Toll Tops 110,000, Senior Health Official Says
    Physician in Mexico Admitted to Intensive Care Unit After Receiving Pfizer Vaccine
    Argentina, Mexico, COVID-19, Sputnik V
    Community standardsDiscussion